Isra Levy

794 total citations
20 papers, 558 citations indexed

About

Isra Levy is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Isra Levy has authored 20 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Isra Levy's work include Prostate Cancer Diagnosis and Treatment (6 papers), Global Cancer Incidence and Screening (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Isra Levy is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (6 papers), Global Cancer Incidence and Screening (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Isra Levy collaborates with scholars based in Canada, United States and India. Isra Levy's co-authors include William G. Woods, Ru‐Nie Gao, Bernard Lemieux, Mark L. Bernstein, Jonathan J. Shuster, Josée Brossard, Greta R. Bunin, Mendel Tuchman, Leslie L. Robison and Geoffrey Dougherty and has published in prestigious journals such as New England Journal of Medicine, Transfusion and Cancer Causes & Control.

In The Last Decade

Isra Levy

20 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isra Levy Canada 13 171 150 137 102 89 20 558
Marianne Davies United States 14 482 2.8× 59 0.4× 138 1.0× 110 1.1× 77 0.9× 38 795
Annelies Janssens Belgium 18 360 2.1× 49 0.3× 333 2.4× 82 0.8× 48 0.5× 62 767
Henrik W. Finnern United States 12 208 1.2× 49 0.3× 208 1.5× 43 0.4× 22 0.2× 24 597
Claire Lethrosne France 6 454 2.7× 49 0.3× 155 1.1× 130 1.3× 75 0.8× 6 618
Benjamin Barnes Germany 13 257 1.5× 29 0.2× 63 0.5× 121 1.2× 54 0.6× 29 530
Arturo Fajardo‐Gutiérrez Mexico 16 174 1.0× 55 0.4× 59 0.4× 354 3.5× 324 3.6× 77 727
Alexander E. Sherman United States 12 262 1.5× 90 0.6× 67 0.5× 134 1.3× 37 0.4× 31 728
Catherine Bender United States 10 162 0.9× 21 0.1× 45 0.3× 102 1.0× 104 1.2× 16 462
F. Cavalli Switzerland 11 119 0.7× 24 0.2× 62 0.5× 203 2.0× 103 1.2× 28 418
Robison Ll United States 7 223 1.3× 57 0.4× 130 0.9× 356 3.5× 350 3.9× 12 805

Countries citing papers authored by Isra Levy

Since Specialization
Citations

This map shows the geographic impact of Isra Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isra Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isra Levy more than expected).

Fields of papers citing papers by Isra Levy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isra Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isra Levy. The network helps show where Isra Levy may publish in the future.

Co-authorship network of co-authors of Isra Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Isra Levy. A scholar is included among the top collaborators of Isra Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isra Levy. Isra Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prokopchuk‐Gauk, Oksana, et al.. (2021). Blood shortages planning in Canada: The National Emergency Blood Management Committee experience during the first 6 months of the COVID‐19 pandemic. Transfusion. 61(11). 3258–3266. 10 indexed citations
2.
Ellis, Edward, Carla Osiowy, Anton Andonov, et al.. (2015). Public Health Response to a Large‐scale Endoscopy Infection Control Lapse in a Nonhospital Clinic. Canadian Journal of Infectious Diseases and Medical Microbiology. 26(2). 77–84. 8 indexed citations
3.
Sanmartin, Claudia, Tom Noseworthy, Morris L. Barer, et al.. (2003). Toward Standard Definitions for Waiting Times. Healthcare Management Forum. 16(2). 49–53. 14 indexed citations
4.
Woods, William G., Ru‐Nie Gao, Jonathan J. Shuster, et al.. (2002). Screening of Infants and Mortality Due to Neuroblastoma. New England Journal of Medicine. 346(14). 1041–1046. 220 indexed citations
5.
Kaufman, David, et al.. (2002). Achieving cardiovascular health through continuing interprofessional development.. PubMed. 92(4). I10–6. 5 indexed citations
6.
Kaufman, David, et al.. (2001). Achieving Cardiovascular Health Through Continuing Interprofessional Development. Canadian Journal of Public Health. 92(4). I10–I16. 3 indexed citations
7.
McClaran, Jacqueline, et al.. (2001). From Death and Disability to Patient Empowerment: An Interprofessional Partnership to Achieve Cardiovascular Health in Canada. Canadian Journal of Public Health. 92(4). I3–I9. 10 indexed citations
8.
Krahn, Murray, et al.. (1999). Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.. PubMed. 160(1). 49–57. 19 indexed citations
9.
Johnston, Grace, et al.. (1998). Identifying potential need for cancer palliation in Nova Scotia.. PubMed. 158(13). 1691–8. 33 indexed citations
10.
Mercer, Shawna L., Vivek Goel, Isra Levy, et al.. (1998). Prostate cancer screening in the midst of controversy: Canadian men's knowledge, beliefs, utilization, and future intentions.. PubMed. 88(5). 327–32. 33 indexed citations
11.
Levy, Isra, N. Iscoe, & Laurence Klotz. (1998). Prostate cancer: 1. The descriptive epidemiology in Canada.. PubMed. 159(5). 509–13. 17 indexed citations
12.
Ellison, Larry F., et al.. (1998). Monograph series on aging-related diseases: X. Prostate cancer.. PubMed. 19(1). 1–18. 15 indexed citations
13.
Eapen, Libni, et al.. (1998). Comorbid survival among elderly male participants of the Canada health survey: relevance to prostate cancer screening and treatment.. PubMed. 19(3). 84–90. 13 indexed citations
14.
Gao, Ru‐Nie, et al.. (1997). Incidence and mortality of neuroblastoma in Canada compared with other childhood cancers. Cancer Causes & Control. 8(5). 745–754. 19 indexed citations
15.
Mercer, Shawna L., Vivek Goel, Isra Levy, et al.. (1997). Prostate Cancer Screening in the Midst of Controversy: Canadian Men’s Knowledge, Beliefs, Utilization, and Future Intentions. Canadian Journal of Public Health. 88(5). 327–332. 27 indexed citations
16.
Snider, Judy, et al.. (1996). Trends in mammography and Pap smear utilization in Canada.. PubMed. 17(3-4). 108–17. 44 indexed citations
17.
Miller, D. Claire, et al.. (1996). The impending Canadian prostate cancer epidemic.. PubMed. 86(4). 274–8. 11 indexed citations
18.
Levy, Isra. (1994). Prostate cancer: the epidemiologic perspective.. PubMed. 4 Suppl 1. 4–7. 6 indexed citations
19.
Gibbons, Laurie, Yukang Mao, Isra Levy, & A. B. Miller. (1994). The Canadian Childhood Cancer Control Program.. PubMed. 151(12). 1704–9. 18 indexed citations
20.
Levy, Isra, et al.. (1993). Prostate cancer trends in Canada: rising incidence or increased detection?. PubMed. 149(5). 617–24. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianne Davies Breakdown of academic impact, for papers by Annelies Janssens Breakdown of academic impact, for papers by Henrik W. Finnern Breakdown of academic impact, for papers by Claire Lethrosne Breakdown of academic impact, for papers by Benjamin Barnes Breakdown of academic impact, for papers by Arturo Fajardo‐Gutiérrez Breakdown of academic impact, for papers by Alexander E. Sherman Breakdown of academic impact, for papers by Catherine Bender Breakdown of academic impact, for papers by F. Cavalli Breakdown of academic impact, for papers by Robison Ll
Rankless by CCL
2026